Jeremy S. H. Jackson

TL;DR: Treatment for breast cancer is associated with considerable arm morbidity, which has a negative impact on QOL, andArm morbidity should be carefully monitored in future studies involving local treatment modalities for Breast cancer.

TL;DR: A multivariate analysis of 12 factors predictive of axillary lymph node involvement was conducted in a population-based cohort of 4312 women with invasive breast carcinoma diagnosed between January 1 1993 and December 31, 1996 as mentioned in this paper.

TL;DR: It is found that there is no univariate or multivariate difference in ipsilateral breast cancer recurrence between intervals of 0 to 20 weeks from breast conserving surgery to start of radiation therapy, in a population-based, low risk group of women not receiving adjuvant chemotherapy.

TL;DR: In this prospective but nonrandomized study of treatment for first LRR, the risk of death in the later control cohort was 1.39 times the risk in the chemotherapy cohort but failed to reach statistical significance.

TL;DR: There was little difference among the pilot projects and control for most measures of client satisfaction and anxiety, but differences were found between biopsied and nonbiopsied women for several of these measures.